812P - Health-related quality of life (HRQL) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel (CBZ) in a prospective observational study (CAPRISTANA)
Autor: | Pichler, A., Barnes, G., Katolicka, J., Korunkova, H., Tomova, A., Ghosn, M., El Karak, F., Koroleva, I., Makdessi, J., Ozatilgan, A., Hitier, S., Carles, J. |
---|---|
Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v281-v281 |
Databáze: | ScienceDirect |
Externí odkaz: |